Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces NIH website changes and explains that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    0.5%
    Check dated 2026-10-24T12:25:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T12:58:23.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T12:27:08.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry has been added to the study's history, signaling an updated version of the record. The previous Revision: v3.6.6 entry has been removed from the current history display.
    Difference
    0.1%
    Check dated 2026-09-19T18:23:20.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the study record history, replacing the previous revision v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T18:45:29.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the record history, replacing the previous v3.6.4. This reflects a minor update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-08-08T20:10:18.000Z thumbnail image

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.